These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [New method for the long-term binding of excess stomach acids]. Tomatis HP; Gumrich H Med Welt; 1970 Aug; 33():1411-5. PubMed ID: 5517790 [No Abstract] [Full Text] [Related]
24. [Enzymatic activity of the gastric and intestinal juices in atrophic gastritis]. Barakov AG; Erashchenko PP; Amirov NSh; Belostotskiĭ NI Ter Arkh; 1980; 52(2):24-6. PubMed ID: 6990533 [No Abstract] [Full Text] [Related]
25. [Comparative data on the activity of gastric proteolytic enzymes in pathological states of the stomach including cancer]. Iansone IL Klin Lech Zlokach Novoobraz; 1968; 11():15-7. PubMed ID: 5725402 [No Abstract] [Full Text] [Related]
26. [Clinical evaluation, in gastritis and gastroduodenal ulcers of a new non-anticholinergic compound with protective and antisecretory activity]. Fantino M; Roccia L Minerva Med; 1967 Oct; 58(86):3677-85. PubMed ID: 6061061 [No Abstract] [Full Text] [Related]
27. [Secretory function and enzyme activity in chronic gastritis]. Yunoki K Saishin Igaku; 1968 Oct; 23(10):2104-11. PubMed ID: 4975441 [No Abstract] [Full Text] [Related]
28. Lactate dehydrogenase in gastric juice: diagnostic adjunct in human stomach cancer. Faulk WP; Rider JA; Swader JI Lancet; 1972 Nov; 2(7787):1115-7. PubMed ID: 4117205 [No Abstract] [Full Text] [Related]
29. [Clinical value of the total lactate dehydrogenase (LDH) activity of gastric juice in the diagnosis malignant and precancerous states of the stomach]. Simon L; Paksy A; Figus IA Orv Hetil; 1969 Nov; 110(45):2635-40. PubMed ID: 5362071 [No Abstract] [Full Text] [Related]
30. [Therapeutic effect of a new antisecretory and antacid medication]. Galli L; Bissi A Minerva Chir; 1968 May; 23(9):477-82. PubMed ID: 4386093 [No Abstract] [Full Text] [Related]
31. [The normal digestion of protein-containing food products by gastric juice and in pathology of the gastrointestinal tract]. Gerasimov VK; Rumiantsev SN; Tugolukov VN Ter Arkh; 1989; 61(11):62-4. PubMed ID: 2699097 [TBL] [Abstract][Full Text] [Related]
32. [Controlled clinical evaluation of the therapeutic value of antacid-antiulcer preparation]. Lattanzi A; De Liperi E Minerva Med; 1967 Oct; 58(87):3736-43. PubMed ID: 6075229 [No Abstract] [Full Text] [Related]
33. The effect of combined antacid-anticholinergic treatment on the intragastric pH in peptic ulcer disease. Marcussen JM; Vilsvik JS Scand J Gastroenterol; 1968; 3(2):170-6. PubMed ID: 5711480 [No Abstract] [Full Text] [Related]
35. [Medical therapy of gastric and duodenal ulcer]. Dioguardi N Minerva Med; 1977 Nov; 68(55):3729-32. PubMed ID: 593591 [No Abstract] [Full Text] [Related]
36. The use of antacids in the treatment of peptic ulcer. Grossman MI Scand J Gastroenterol Suppl; 1980; 58():37-40. PubMed ID: 6988940 [No Abstract] [Full Text] [Related]